Trastuzumab Deruxtecan Shows Clinically Meaningful Response in Non-Small Cell Lung Cancer

Retrieved on: 2022-09-13 18:21:50

Tags for this article:

Click the tags to see associated articles and topics

Trastuzumab Deruxtecan Shows Clinically Meaningful Response in Non-Small Cell Lung Cancer. View article details on hiswai:

Excerpt

Trastuzumab deruxtecan (Enhertu; AstraZeneca, Daiichi Sankyo) demonstrated clinically meaningful tumor responses in previously treated patients ...

Article found on: www.pharmacytimes.com